6.57 USD
↗ 0.25 (3.96%)AT CLOSE (11:59 AM EDT)
Clene Inc. Common Stock
CLNNNASDAQ • USD
6.67
↗ 0.10 (1.45%)
POST MARKET (AS OF 07:08 PM EDT)
Post Market
AS OF 07:08 PM EDT
6.67
↗ 0.10 (1.45%)
Market: CLOSED
Open?$6.49
High?$7.17
Low?$6.42
Prev. Close?$6.32
Volume?80.5K
Avg. Volume?89.6K
VWAP?$6.80
Rel. Volume?0.90x
Bid / Ask
Bid?$5.49 × 100
Ask?$7.81 × 100
Spread?$2.32
Midpoint?$6.65
Valuation & Ratios
Market Cap?74.4M
Shares Out?11.8M
Float?7.4M
Float %?68.6%
P/E Ratio?N/A
P/B Ratio?-4.23
EPS?-$2.22
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.83Weak
Quick Ratio?0.83Weak
Cash Ratio?0.48Low
Debt/Equity?-1.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?-4.23CHEAP▾
P/S?372.19HIGH▾
P/FCF?N/A▾
EV/EBITDA?-4.0CHEAP▾
EV/Sales?434.32HIGH▾
Returns & Efficiency
ROE?148.4%STRONG▾
ROA?-144.0%WEAK▾
Cash Flow & Enterprise
FCF?$-18585000
Enterprise Value?$86.9M
News
Profile
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50
SALT LAKE CITY, UT 84121
Phone: 801-676-9695
SALT LAKE CITY, UT 84121
Phone: 801-676-9695